Abstract:OBJECTIVE: To evaluate the effect of short- and long-term administration of melatonin on central brain-derived neurotrophic factor (BDNF) levels in rats with acute and chronic inflammatory pain.METHODS: The animals were allocated to one of two experiments: experiment 1 or experiment 2. In experiment 1, all animals were injected with complete Freund's adjuvant (CFA) to induce inflammation and were randomly allocated to receiving melatonin (60 mg/kg) or vehicle. Injections were administered 1 h after CFA and once daily for 2 more days (for a total of 3 days of melatonin administration). In experiment 2, fifteen days after CFA injection, the animals were treated with melatonin (50 mg/kg) or vehicle for 8 days. The animals were killed by decapitation 24 h after the last melatonin or vehicle administration, and an ELISA assay was performed to detect BDNF expression in the spinal cord, brainstem, and prefrontal cortex of the rats in both groups. Data were analyzed using Student's t test and the results are expressed as means ± SEM.RESULTS: In the first experiment, the BDNF levels of the melatonin group were reduced in the prefrontal cortex (Student's t test, p = 0.01) and increased in the spinal cord (Student's t test, p = 0.04). In experiment 2, BDNF levels were similar in both groups for all structures (Student's t test, p > 0.00 for all). A two-way ANOVA reveled a significant effect of structures (p = 0.0001) but not of treatment (p > 0.05). The prefrontal cortex presented higher BDNF levels than other structures (ANOVA/Student-Newman-Keuls test, p = 0.0001). Considering the relationship between BDNF levels in all three structures, we found an effect of central nervous system structures (p = 0.01) and an interaction between treatment and structures (p = 0.04).CONCLUSION: The high spinal cord BDNF levels and the low prefrontal cortical BDNF levels observed in rats with acute CFA-induced inflammation following short-term melatonin administration may be related to the pain-modulating and neuroprotective effects of this protein. Long-term melatonin administration did not alter BDNF levels in chronic inflammation.

Melatonin Attenuates the Intensity of Beta-Endorphin Immunoreactivity in the Arcuate Nucleus of Rat Hypothalamus.

[Effect of Melatonin on Release of Beta-Endorphin, Norepinephrine and 5-Hydroxytryptamine in Rat Brain].

Effect of Melatonin on the Level of Dynorphin in Rat Brain

Melatonin Influences the Release of Endogenous Opioid Peptides in Rat Periaqueductal Gray

Effect of Melatonin on Pro-Opiomelanocortin Mrna Expression in Arcuate Nucleus of Rat Hypothalamus

The Analgesic Effects of Peripheral and Central Administration of Melatonin in Rats.

Changes of Cerebral Β-Endorphin in Rats Treated with Combination Therapy of Melatonin and Electroacupuncture

Melatonin reverses morphine tolerance by inhibiting microglia activation and HSP27 expression

Melatonin Blocks Morphine-Induced Place Preference: Involvement of GLT-1, NF-κB, BDNF, and CREB in the Nucleus Accumbens

Melatonin Attenuates Inflammatory Response‐induced Brain Edema in Early Brain Injury Following a Subarachnoid Hemorrhage: a Possible Role for the Regulation of Pro‐inflammatory Cytokines

Melatonin alleviates morphine analgesic tolerance in mice by decreasing NLRP3 inflammasome activation

Melatonin Improves Mitochondrial Dysfunction and Attenuates Neuropathic Pain by Regulating SIRT1 in Dorsal Root Ganglions

INHIBITORY EFFECT OF MELATONIN ON cAMP LEVEL OF CEREBROSPINAL FLUID AND PLASMA IN MORPHINE WITHDRAWAL RATS

Does exogenous melatonin influence the metabolism of free radicals and pain sensation in the rat?

Exogenous melatonin alleviates neuropathic pain-induced affective disorders by suppressing NF-κB/ NLRP3 pathway and apoptosis

Short- but Not Long-Term Melatonin Administration Reduces Central Levels of Brain-Derived Neurotrophic Factor in Rats with Inflammatory Pain

Melatonin attenuates morphine‐induced conditioned place preference in Wistar rats

Melatonin Arrests Peroxynitrite-Induced Tau Hyperphosphorylation And The Overactivation Of Protein Kinases In Rat Brain

Alteration of Orphanin FQ Immunoreactivity and Ppofq Mrna by Combination of Melatonin with Electroacupuncture

Melatonin Attenuates Pyroptosis Upon Spinal Nerve Ligation in Rats via the NF-κB/NLRP3 Inflammasome Signaling Pathway

Melatonin Decreases Neurovascular Oxidative/nitrosative Damage and Protects Against Early Increases in the Blood-Brain Barrier Permeability after Transient Focal Cerebral Ischemia in Mice.